Investment led by Jon Moulton supports progression of clinical and preclinical programmes addressing critical-priority pathogensInfex to present ...
Infex Therapeutics, an anti-infectives specialist based at Alderley Edge, has secured £4.3m in funding, led by prominent ...
This Collection invites perspectives on the historical, socio-cultural and bio-medical facets of anti-infectives, including failure and success stories of anti-infective drugs, a discourse of ...
PRINCETON, N.J.--(BUSINESS WIRE)--ArrePath, an anti-infective drug discovery company addressing the global health challenge of drug resistant infections, announced today that it has raised $20 million ...
Orthogon Therapeutics, a privately held research and development (R&D) company, uses principles of biophysics and structure-based drug design to develop anti-infective small molecules that selectively ...
Smart planning can reduce scours risk and help maintain antimicrobial effectiveness. Dr. Brett Terhaar, has practical tips you need for healthier herds ...
MORRISTOWN, N.J.--(BUSINESS WIRE)--Melinta Therapeutics (Melinta) and Hikma Pharmaceuticals PLC (Hikma) today announced they have entered into an exclusive licensing agreement for Vabomere ® ...
Recce Pharmaceuticals has secured an Australian patent for its innovative anti-infective drugs, R327 and R529, ensuring its intellectual property protection in all major pharmaceutical markets until ...
Recce Pharmaceuticals’ synthetic gel successfully treated a range of skin infections in a phase 2 trial, leading the Australian biotech to point to the anti-infective's potential to counter ...
SYDNEY, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX:RCE, FSE:R9Q), the Company developing a new class of synthetic anti-infectives, today announced the Australian Patent Office ...
Aicuris Anti-infective Cures AG has announced its intention to focus on the development and commercialization of anti-infectives for immunocompromised individuals, and will discontinue research ...
CNW/ - Stoked Bio Inc., a Canadian biotechnology company focused on the development of novel anti-infectives and cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results